Soleno Therapeutics, Inc. (SLNO)
USD 68.29
(-5.36%)
USD 68.29
(-5.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 1.95 Million | 2.21 Million | 2.2 Million | 2.19 Million | 2.29 Million | 1.91 Million |
| Gross Profit | -1.95 Million | -2.21 Million | -2.2 Million | -2.19 Million | -2.29 Million | -1.91 Million |
| Operating Expenses | 41.38 Million | 25.1 Million | 32.25 Million | 31.94 Million | 23.19 Million | 13.73 Million |
| Selling, General and Administrative Expenses | 13.48 Million | 9.84 Million | 10.8 Million | 8.75 Million | 6.93 Million | 6.55 Million |
| Research and Development Expenses | 25.18 Million | 15.26 Million | 21.45 Million | 23.19 Million | 16.26 Million | 7.17 Million |
| Other Expenses | 2.71 Million | - | - | 4.34 Million | 289 Thousand | 6000.00 |
| Cost and Expenses | 41.38 Million | 25.1 Million | 32.25 Million | 31.94 Million | 23.19 Million | 13.73 Million |
| Operating Income | -41.38 Million | -24.39 Million | -31.52 Million | -36.28 Million | -23.48 Million | -14.3 Million |
| Interest Expense | - | - | - | - | - | 62 Thousand |
| Income Tax Expense | - | -3.74 Million | -1.34 Million | -9.26 Million | 5.14 Million | 2.52 Million |
| Earnings before Tax | -38.98 Million | -24.06 Million | -30.91 Million | -24.63 Million | -30.77 Million | -11.84 Million |
| Net Income | -38.98 Million | -20.31 Million | -29.56 Million | -15.37 Million | -35.91 Million | -13.33 Million |
| Earnings Per Share Basic | -2.36 | -2.42 | -5.56 | -3.68 | -15.78 | -9.54 |
| Earnings Per Share Diluted | -2.36 | -2.42 | -5.56 | -3.68 | -15.78 | -9.54 |
| Weighted Average Shares Outstanding | 16.49 Million | 8.39 Million | 5.31 Million | 4.17 Million | 2.27 Million | 1.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 16.49 Million | 8.39 Million | 5.31 Million | 4.17 Million | 2.27 Million | 1.39 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -37.03 Million | -21.85 Million | -28.7 Million | -29.99 Million | -28.47 Million | -9.92 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 3.44 Million | - | - | - |
| Cost of Revenue | 494 Thousand | 490 Thousand | 489 Thousand | 1.95 Million | 557 Thousand | 598 Thousand |
| Gross Profit | -494 Thousand | -490 Thousand | 2.95 Million | -1.95 Million | -557 Thousand | -598 Thousand |
| Operating Expenses | 22.73 Million | 23.47 Million | 12.34 Million | 36.71 Million | 10.38 Million | 8.31 Million |
| Selling, General and Administrative Expenses | 10.39 Million | 8.47 Million | 3.65 Million | - | 3.31 Million | 3.16 Million |
| Research and Development Expenses | 12.34 Million | 14.6 Million | 8.68 Million | - | 6.04 Million | 5.14 Million |
| Other Expenses | 1.63 Million | 401 Thousand | 1.08 Million | 2.71 Million | 1.02 Million | 313 Thousand |
| Cost and Expenses | 23.23 Million | 23.47 Million | 12.82 Million | 38.67 Million | 10.38 Million | 8.31 Million |
| Operating Income | -23.23 Million | -21.39 Million | -12.82 Million | -38.67 Million | -10.86 Million | -8.62 Million |
| Interest Expense | - | - | 113 Thousand | - | - | - |
| Income Tax Expense | - | 1.18 Million | 2 Million | - | -2.16 Million | 165 Thousand |
| Earnings before Tax | -21.85 Million | -21.39 Million | -11.29 Million | -38.98 Million | -10.86 Million | -8.47 Million |
| Net Income | -21.85 Million | -21.39 Million | -11.29 Million | -38.98 Million | -10.86 Million | -8.47 Million |
| Earnings Per Share Basic | -0.57 | -0.59 | -0.33 | - | -0.95 | -0.81 |
| Earnings Per Share Diluted | -0.57 | -0.59 | -0.33 | - | -0.95 | -0.81 |
| Weighted Average Shares Outstanding | 38.63 Million | 36.2 Million | 34.38 Million | 16.49 Million | 11.43 Million | 10.42 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.63 Million | 36.2 Million | 34.44 Million | 16.49 Million | 11.43 Million | 10.42 Million |
| Gross Margin | - | - | 0.86 | - | - | - |
| EBIT Margin | - | - | -3.58 | - | - | - |
| Profit Margin | - | - | -3.28 | - | - | - |
| EBITDA | -22.73 Million | -21.39 Million | -12.34 Million | - | -10.86 Million | -7.5 Million |
| Earnings Before Tax Margin | - | - | -3.72 | - | - | - |
4488
SAFT
300127
3760
TSLA
002450